Every trade that managers of UiPath, Inc. disclose to SEC (Form 4) is tracked on this page. The company sits in the Technology sector and is based in New York City, United States. It was founded in 2005. Over the twelve months to 18 October 2026, 97 filings were filed, from 13 insiders.
There is no open-market purchase to report; the filings show 47 sales worth €47.2M by 5 insiders. Dines Daniel filed the largest sale, €19.5M, on 19 August 2026, which represents 0.34% of the company's market value.
Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
For context, the typical company on the same exchange (median of 5,810 companies) published 19 filings over the same period, against 97 filings here. Our records for UiPath, Inc. go back to 2021, with no purchases and 193 sales on the open market in total. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 January 2026), the company reported revenue of 1.61 bn USD and net income of 282.3 m USD.
For comparison within the same sector, see the insider buying recorded at Core Scientific, Inc./tx and Gitlab Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended January 2026 · cache
25 of 418 declarations
UiPath, Inc. is a U.S.-based enterprise software company listed on the NYSE under the ticker PATH, with its corporate headquarters in New York, United States, and a global operating footprint. The company was founded in 2005 in Bucharest, Romania, and has grown from a small automation startup into a widely recognized platform vendor focused on helping enterprises automate business processes. Its original foundation was in robotic process automation (RPA), but UiPath has since broadened its scope toward agentic automation, workflow orchestration, and AI-enabled enterprise operations. ([uipath.com](https://www.uipath.com/about-us?utm_source=openai))
At the center of the business is the UiPath Platform, a software suite designed to automate, manage, test, and govern repetitive or complex work across heterogeneous IT environments. The platform spans automation design, orchestration, software testing, document understanding, AI integration, and centralized governance. In practical terms, UiPath sells a mission-critical productivity layer that helps customers reduce manual effort, improve process consistency, and scale automation across departments and geographies. This positions the company as more than a pure RPA vendor; it is increasingly presenting itself as an end-to-end automation and orchestration platform. ([uipath.com](https://www.uipath.com/product/platform?utm_source=openai))
From a competitive standpoint, UiPath remains one of the best-known names in enterprise automation. The company highlights repeated recognition from industry analysts, including leadership positions in RPA and broader intelligent automation categories. Its competitive strengths include a substantial installed base, a strong brand among automation buyers, a large developer and partner ecosystem, and an expanding product portfolio aimed at capturing the shift from rule-based automation to AI-driven agentic workflows. That evolution matters strategically because it helps UiPath defend relevance as customer expectations move beyond traditional bots toward orchestration of agents, people, and systems. ([uipath.com](https://www.uipath.com/about-us?utm_source=openai))
UiPath serves customers across more than 100 countries, underscoring a genuinely international revenue opportunity. The company’s customer base is diversified across industries such as financial services, manufacturing, retail, healthcare, public sector, and other large-enterprise verticals. Geographically, UiPath remains global in sales and delivery, although it is firmly anchored in the United States for capital-market purposes and as a New York–headquartered issuer. ([uipath.com](https://www.uipath.com/about-us?utm_source=openai))
Recent developments reinforce the company’s strategic pivot. In 2025, UiPath announced expanded capabilities for its platform around agentic automation and orchestration, signaling continued investment in AI-native workflow automation. The company also referenced product releases and acquisitions intended to strengthen its automation, testing, and governance stack. For investors, UiPath is therefore a U.S.-listed software name on the NYSE that sits at the intersection of automation and enterprise AI, with attractive long-term platform potential but exposure to execution risk, competitive intensity, and spending cycles in enterprise IT. ([uipath.com](https://www.uipath.com/newsroom/uipath-accelerates-ai-transformation-with-agentic-automation-and-orchestration?utm_source=openai))
Purchases our model currently ranks for the recommendations list.
All recommendationsInsider filings
Over the last 90 days, 35 filings published between 13 August and 15 October 2026: 9 sales for €24.7M. 26 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers). Largest amounts: Dines Daniel (CEO and Chairman), sales of €19.5M; Gupta Ashim (COO), sales of €2.2M; Malpani Raghavendra (CPO & CTO), sales of €2.0M.
Recent news
From Zonebourse Suisse on 23 September 2026: "UiPath, Inc. annonce de nouvelles améliorations, ainsi que des améliorations prévues, de UiPath Test Cloud" (headline in French).
Headlines quoted as published, with source and date. The gap to insider purchases is computed from the filings and implies no link between the article and the purchase. Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 17 October 2026 (UTC)
Headquarters: New York City, United States · Founded: 2005 · Wikipedia article
Source: Wikidata (CC0).
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Jan 2026 | 1.61 bn USD | 282.3 m USD | 0.52 USD | 10-K |
| Jan 2025 | 1.43 bn USD | -73.7 m USD | -0.13 USD | 10-K |
| Jan 2024 | 1.31 bn USD | -89.9 m USD | -0.16 USD | 10-K |
| Jan 2023 | 1.06 bn USD | -328.4 m USD | -0.60 USD | 10-K |
| Jan 2022 | 892.3 m USD | -525.6 m USD | -1.16 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.